ABOUT LINK ALTERNATIF MBL77

Not all sufferers with CLL require therapy. Irrespective of all modern improvements, the iwCLL still endorses watchful observation for clients with asymptomatic condition.86 This recommendation relies on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).